STX
45
-11
MCO
78
-2
CL
58
-4
EMC
65
6
F
43
-3
O
20
-2
SO
51
-4
AIV
67
-5
ADM
33
-4
LNC
36
-4
PM
58
-2
KHC
15
-2
NSC
60
-2
UHS
56
-2
LYB
39
-2
BAX
33
-3
CPB
30
-9
FRT
41
-4
IP
67
2
NWS
90
26
STX
45
-11
MCO
78
-2
CL
58
-4
EMC
65
6
F
43
-3
O
20
-2
SO
51
-4
AIV
67
-5
ADM
33
-4
LNC
36
-4
PM
58
-2
KHC
15
-2
NSC
60
-2
UHS
56
-2
LYB
39
-2
BAX
33
-3
CPB
30
-9
FRT
41
-4
IP
67
2
NWS
90
26
Financhill
Back

CME Group Vs. NovoCure Industry Stock Comparison

Buy
67

CME
CME Group

Last Price:
242.22
Seasonality Move:
5.4%
Buy
77

NVCR
NovoCure

Last Price:
28.80
Seasonality Move:
2.04%
Buy
67
CME Group (CME) is a Buy

Is CME Group a Buy, Sell or Hold?

  • The current CME Group [CME] share price is $240.73. The Score for CME is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • CME is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CME Stock Price Chart

What is CME Group's stock price today?

  • The CME Group share price today is $240.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CME is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

CME Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.54 Buy
Relative Strength Index (14 RSI): 69.79 Buy
Chaikin Money Flow: 2509879 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (223.18 - 233.28) Buy
Bollinger Bands (100): (205.22 - 227.96) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

CME Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 233.88 Buy
20-day SMA: 228.97 Buy
50-day SMA: 225.78 Buy
200-day SMA: 212.64 Buy
8-day EMA: 234.92 Buy
20-day EMA: 230.79 Buy
50-day EMA: 225.61 Buy
200-day EMA: 214.28 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

CME Group Earnings Growth & CME Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.16 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

CME Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):